Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

被引:23
|
作者
Hirata Katayama, Maria Lucia [1 ]
Costa Vieira, Rene Aloisio [2 ]
Andrade, Victor Piana [3 ]
Roela, Rosimeire Aparecida [1 ]
Cernaglia Aureliano Lima, Luiz Guilherme [3 ]
Kerr, Ligia Maria [4 ]
de Campos, Adriano Polpo [5 ,6 ]
de Braganca Pereira, Carlos Alberto [7 ]
de Menezes Pacheco Serio, Pedro Adolpho [1 ]
Encinas, Giselly [1 ]
Maistro, Simone [1 ]
Leite Petroni, Matheus de Almeida [1 ]
Brentani, Maria Mitzi [1 ]
Azevedo Koike Folgueira, Maria Aparecida [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med,Dept Radiol & Oncol, Ctr Invest Translac Oncol,Inst Canc Estado Sao Pa, BR-01246000 Sao Paulo, SP, Brazil
[2] Hosp Canc Barretos, Dept Mastol, BR-14784400 Barretos, SP, Brazil
[3] AC Camargo Canc Ctr, BR-01525001 Sao Paulo, SP, Brazil
[4] Hosp Canc Barretos, Dept Patol, BR-14784400 Barretos, SP, Brazil
[5] Univ Fed Sao Carlos, Ctr Ciencias Exatas & Tecnol, Dept Estat, BR-13565905 Sao Carlos, SP, Brazil
[6] Univ Western Australia, Dept Math & Stat, M019,35 Stirling Highway, Crawley, WA 6009, Australia
[7] Univ Sao Paulo, Inst Matemat & Estat, Dept Estat, BR-05508090 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
breast cancer; stromal cells; gene expression; chemotherapy neoadjuvant; GENE-EXPRESSION; ESTROGEN-RECEPTOR; ENRICHMENT ANALYSIS; EPITHELIAL-CELLS; TUMOR-STROMA; IDENTIFICATION; PROGRAM; ALPHA;
D O I
10.3390/cells8121566
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Breast cancer stromal compartment, may influence responsiveness to chemotherapy. Our aim was to detect a stromal cell signature (using a direct approach of microdissected stromal cells) associated with response to neoadjuvant chemotherapy (neoCT) in locally advanced breast cancer (LABC). The tumor samples were collected from 44 patients with LABC (29 estrogen receptor (ER) positive and 15 ER negative) before the start of any treatment. Neoadjuvant chemotherapy consisted of doxorubicin and cyclophosphamide, followed by paclitaxel. Response was defined as downstaging to maximum ypT1a-b/ypN0. The stromal cells, mainly composed of fibroblast and immune cells, were microdissected from fresh frozen tumor samples and gene expression profile was determined using Agilent SurePrint G3 Human Gene Expression microarrays. Expression levels were compared using MeV (MultiExperiment Viewer) software, applying SAM (significance analysis of microarrays). To classify samples according to tumor response, the order of median based on confidence statements (MedOr) was used, and to identify gene sets correlated with the phenotype downstaging, gene set enrichment analysis (GSEA). Nine patients presented disease downstaging. Eleven sequences (FDR 17) were differentially expressed, all of which (except H2AFJ) more expressed in responsive tumors, including PTCHD1 and genes involved in abnormal cytotoxic T cell physiology, TOX, LY75, and SH2D1A. The following four pairs of markers could correctly classify all tumor samples according to response: PTCHD1/PDXDC2P, LOC100506731/NEURL4, SH2D1A/ENST00000478672, and TOX/H2AFJ. Gene sets correlated with tumor downstaging (FDR < 0.01) were mainly involved in immune response or lymphocyte activation, including CD47, LCK, NCK1, CD24, CD3E, ZAP70, FOXP3, and CD74, among others. In locally advanced breast cancer, stromal cells may present specific features of immune response that may be associated with chemotherapy response.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer
    Moll, UM
    Chumas, J
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1997, 193 (03) : 187 - 196
  • [42] Use of neoadjuvant chemotherapy in locally advanced breast cancer in the Netherlands
    Spronk, P. E. R.
    Van Bommel, A. C. M.
    Siesling, S.
    Peeters, M. J. T. Baas-Vrancken
    Smorenburg, C. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S93 - S93
  • [43] Combined Neoadjuvant Chemotherapy and Celecoxib in Locally Advanced Breast Cancer
    Ahmadloo, N.
    Mozaffari, M. A. Nazer
    Mohammadianpanah, M.
    Omidvari, S. H.
    Mosalaei, A.
    Shirazi, M. A. Mosleh
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2009, 11 (04) : 419 - 424
  • [44] Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy
    Hattangadi, Jona
    Park, Catherine
    Rembert, James
    Klifa, Catherine
    Hwang, Jimmy
    Gibbs, Jessica
    Hylton, Nola
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (06) : 1630 - 1636
  • [45] Role of breast imaging with histopathological correlation in evaluating the response of locally advanced breast cancer to neoadjuvant chemotherapy
    Syed, Anjum
    Premi, Vimugdha
    Varghese, Reshma
    Arora, Manali
    Kapoor, Aakriti
    Kattupalli, Satish
    Sharda, Prateek
    Gupta, Manoj
    Ravi, Bina
    [J]. BREAST JOURNAL, 2020, 26 (11): : 2272 - 2275
  • [46] Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer
    Kentaro Sekizawa
    Kazuya Nakagawa
    Yasushi Ichikawa
    Hirokazu Suwa
    Mayumi Ozawa
    Masashi Momiyama
    Atsushi Ishibe
    Jun Watanabe
    Mitsuyoshi Ota
    Ikuma Kato
    Itaru Endo
    [J]. Surgery Today, 2022, 52 : 198 - 206
  • [47] Relationship between stromal regulatory T cells and the response to neoadjuvant chemotherapy for locally advanced rectal cancer
    Sekizawa, Kentaro
    Nakagawa, Kazuya
    Ichikawa, Yasushi
    Suwa, Hirokazu
    Ozawa, Mayumi
    Momiyama, Masashi
    Ishibe, Atsushi
    Watanabe, Jun
    Ota, Mitsuyoshi
    Kato, Ikuma
    Endo, Itaru
    [J]. SURGERY TODAY, 2022, 52 (02) : 198 - 206
  • [48] Defining novel stromal and tumour characteristics associated with response to neoadjuvant chemotherapy in breast cancer
    Pourreyron, Celine
    Waugh, Shelley
    Whelehan, Patsy
    Coates, Philip
    Jordan, Lee
    Purdie, Colin
    Vinnicombe, Sarah
    Thompson, Alastair
    Evans, Andrew
    Fuller-Pace, Frances
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 192 - 192
  • [49] EarlyR signature predicts response to neoadjuvant chemotherapy in breast cancer
    Buechler, Steven A.
    Gokmen-Polar, Yesim
    Badve, Sunil S.
    [J]. BREAST, 2019, 43 : 74 - 80
  • [50] CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
    Wilson Eduardo Furlan Matos Alves
    Murilo Bonatelli
    Rozany Dufloth
    Lígia Maria Kerr
    Guilherme Freire Angotti Carrara
    Ricardo Filipe Alves da Costa
    Cristovam Scapulatempo-Neto
    Daniel Tiezzi
    René Aloísio da Costa Vieira
    Céline Pinheiro
    [J]. BMC Cancer, 19